Dr. Cristian Alexander Speil, MD

Dr. Speil practices at Northwest Community Hospital in Arlington Heights, Illinois, part of Endeavor Health.

Dr. Speil's NPI, 1346243730, was assigned on May 31, 2005. Dr. Speil graduated from Carol Davila University of Medicine and Pharmacy in 1994. Dr. Speil holds Illinois license 036-115015.

Dr. Speil's primary practice is Northwest Community Hospital, at 800 W Central Road, Arlington Heights, IL 60005 in Cook County. The practice phone is (847) 618-1000.

Dr. Speil's primary practice is Northwest Community Hospital in Arlington Heights, Illinois, part of Endeavor Health. The medical group on file is Northwest Suburban Medical Associates. Dmand AI also links Dr. Speil to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Speil practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Speil's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Speil is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Speil's licenses on file in 2 states: Illinois and Tennessee.

Dmand AI lists acute skin infection, endocarditis, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Speil treats.

CMS data shows 1,185 Medicare services from Dr. Speil across 7 procedure codes in 2024, for 354 Medicare patients. Medicare paid $93,085 for them.

CMS counts 354 Medicare patients who saw Dr. Speil in 2024. The largest group is 75 to 84, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Speil's median patient age at 73, with 40% women.

In 2024, Dr. Speil wrote 525 Medicare Part D claims for 124 patients. 90% of them were for generic drugs. CMS names the drug for 433 of them, across 17 drugs with 11 or more claims each, at $93,794 in total drug cost. In 2023, CMS named 368 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Speil for performance year 2024, reported individually. Dr. Speil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Speil as offering telehealth.

Dmand AI links 4 papers to Dr. Speil, published from 2011 to 2015. Dr. Speil has published most often in Infect Dis Clin North Am. Dr. Speil's most frequent co-authors are Leonard P. Rybak, MD and Susan Yanik.

CMS Open Payments shows 3 general payments to Dr. Speil from 2 drug and device companies from 2021 to 2024. Education make up the largest share, 100% of the total. Melinta Therapeutics, Inc. paid the most, $24.

Dr. Speil graduated from Carol Davila University of Medicine and Pharmacy in 1994.

Dr. Speil is in network with 12 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.